Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
James C Pickford, MD
Internal Medicine · LA PORTE, IN · NPI 1790713733
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 965 | 306 |
| Amlodipine Besylate | Amlodipine Besylate | 470 | 148 |
| Lisinopril | Lisinopril | 417 | 124 |
| Levothyroxine Sodium | Levothyroxine Sodium | 369 | 100 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 255 | 77 |
| Losartan Potassium | Losartan Potassium | 249 | 77 |
| Hydrochlorothiazide | Hydrochlorothiazide | 218 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 194 | 56 |
| Metformin Hcl | Metformin Hcl | 188 | 65 |
| Sertraline Hcl | Sertraline Hcl | 179 | 60 |
| Ezetimibe | Ezetimibe | 172 | 52 |
| Potassium Chloride | Potassium Chloride | 172 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 162 | 59 |
| Tamsulosin Hcl | Tamsulosin Hcl | 158 | 54 |
| Jardiance | Empagliflozin | 153 | 46 |
| Eliquis | Apixaban | 151 | 35 |
| Carvedilol | Carvedilol | 147 | 45 |
| Furosemide | Furosemide | 136 | 46 |
| Omeprazole | Omeprazole | 136 | 44 |
| Gabapentin | Gabapentin | 134 | 39 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 130 | 37 |
| Allopurinol | Allopurinol | 123 | 35 |
| Ozempic | Semaglutide | 122 | 36 |
| Trazodone Hcl | Trazodone Hcl | 115 | 28 |
| Glimepiride | Glimepiride | 114 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 114 | 33 |
| Clonazepam | Clonazepam | 113 | 19 |
| Alendronate Sodium | Alendronate Sodium | 111 | 34 |
| Tramadol Hcl | Tramadol Hcl | 108 | 22 |
| Simvastatin | Simvastatin | 101 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 100 | 32 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 91 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 83 | 24 |
| Nifedipine Er | Nifedipine | 81 | 23 |
| Spironolactone | Spironolactone | 79 | 25 |
| Donepezil Hcl | Donepezil Hcl | 78 | 28 |
| Atenolol | Atenolol | 76 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 75 | 22 |
| Finasteride | Finasteride | 69 | 20 |
| Pregabalin | Pregabalin | 64 | 12 |
| Mounjaro | Tirzepatide | 63 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 61 | 18 |
| Terazosin Hcl | Terazosin Hcl | 61 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 59 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 59 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 52 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 52 | 14 |
| Xarelto | Rivaroxaban | 52 | 13 |
| Celecoxib | Celecoxib | 51 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 50 | 14 |
| Prednisone | Prednisone | 50 | 32 |
| Valsartan | Valsartan | 47 | 14 |
| Meloxicam | Meloxicam | 45 | 14 |
| Chlorthalidone | Chlorthalidone | 44 | 13 |
| Metformin Hcl Er | Metformin Hcl | 43 | 14 |
| Bupropion Xl | Bupropion Hcl | 40 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 40 | 12 |
| Mirtazapine | Mirtazapine | 40 | 14 |
| Montelukast Sodium | Montelukast Sodium | 40 | 16 |
| Warfarin Sodium | Warfarin Sodium | 40 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Verapamil Er | Verapamil Hcl | 38 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 37 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | suppressed |
| Azithromycin | Azithromycin | 33 | 28 |
| Enalapril Maleate | Enalapril Maleate | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 23 |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Klor-Con M10 | Potassium Chloride | 29 | 11 |
| Alprazolam | Alprazolam | 28 | suppressed |
| Famotidine | Famotidine | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 17 |
| Trulicity | Dulaglutide | 25 | suppressed |
| Verapamil Sr | Verapamil Hcl | 25 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 24 | suppressed |
| Memantine Hcl | Memantine Hcl | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 23 | suppressed |
| Klor-Con M20 | Potassium Chloride | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 23 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | 11 |
| Repatha Sureclick | Evolocumab | 22 | suppressed |
| Vascepa | Icosapent Ethyl | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 20 | 14 |
| Sotalol | Sotalol Hcl | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 19 | suppressed |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Glipizide | Glipizide | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 14 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Cephalexin | Cephalexin | 13 | 11 |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 12 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error